galectin-4 Search Results


affinity peptide purified rabbit anti galectin 4 antibody recognizing dkvvfktmqsgq wgkeekc  (Santa Cruz Biotechnology)
93
Santa Cruz Biotechnology affinity peptide purified rabbit anti galectin 4 antibody recognizing dkvvfktmqsgq wgkeekc
Affinity Peptide Purified Rabbit Anti Galectin 4 Antibody Recognizing Dkvvfktmqsgq Wgkeekc, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/galectin-4/galectin-4+Antibody/pm15189734-67-44-58
Average 93 stars, based on 1 article reviews
affinity peptide purified rabbit anti galectin 4 antibody recognizing dkvvfktmqsgq wgkeekc - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier
goat anti galectin 4  (R&D Systems)
93
R&D Systems goat anti galectin 4
Goat Anti Galectin 4, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/galectin-4/Human%2FMouse%2FRat+Galectin-4+Antibody/pm41991671-190-0-18
Average 93 stars, based on 1 article reviews
goat anti galectin 4 - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier
gal 4 antibody  (Novus Biologicals)
91
Novus Biologicals gal 4 antibody
Gal 4 Antibody, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/galectin-4/Galectin-4+Antibody+(9Z2B5)/pmc09808371-81-11-26
Average 91 stars, based on 1 article reviews
gal 4 antibody - by Bioz Stars, 2026-09
91/100 stars
  Buy from Supplier
goat anti gal 3  (R&D Systems)
93
R&D Systems goat anti gal 3
Goat Anti Gal 3, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/galectin-4/Mouse+Galectin-4+Antibody/10__1523_slash_jneurosci__4983___11__2012-52-8-12
Average 93 stars, based on 1 article reviews
goat anti gal 3 - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier
gal4 transcription factor  (ProSci Incorporated)
90
ProSci Incorporated gal4 transcription factor
Gal4 Transcription Factor, supplied by ProSci Incorporated, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/galectin-4/LGALS4+Antibody/pmc03372931-92-23-5
Average 90 stars, based on 1 article reviews
gal4 transcription factor - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
galectin 4  (Santa Cruz Biotechnology)
93
Santa Cruz Biotechnology galectin 4
<t>Galectin-4</t> is significantly downregulated in early recurrent/metastatic hepatocellular carcinoma (HCC). (a) Quantitative PCR analysis of galectin-4 expression in three HCC patient groups with different recurrence/metastasis time. (b) Western blot analysis of galectin-4 expression in three HCC patient groups with different recurrence/metastasis time. (c) Different galectin-4 expression levels in HCC tumor tissues and peri-tumor tissues. Galectin-4 expression was semiquantitatively categorized into four groups: (a) negative (0), (b) weak (1+), (c) moderate (2+), and (d) strong (3+). Original magnification of 20×. * P < 0.05; ** P < 0.01; *** P < 0.001. NR/M, patients with no recurrence/metastasis within 2 years of hepatectomy; R/M ≤12 months , patients with recurrence/metastasis within 12 months of hepatectomy; R/M 12–24 months , patients with recurrence/metastasis within 12–24 months of hepatectomy.
Galectin 4, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/galectin-4/galectin-4+siRNA/pmc04462376-131-7-9
Average 93 stars, based on 1 article reviews
galectin 4 - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier
goat anti gal 4  (R&D Systems)
94
R&D Systems goat anti gal 4
<t>Galectin-4</t> is significantly downregulated in early recurrent/metastatic hepatocellular carcinoma (HCC). (a) Quantitative PCR analysis of galectin-4 expression in three HCC patient groups with different recurrence/metastasis time. (b) Western blot analysis of galectin-4 expression in three HCC patient groups with different recurrence/metastasis time. (c) Different galectin-4 expression levels in HCC tumor tissues and peri-tumor tissues. Galectin-4 expression was semiquantitatively categorized into four groups: (a) negative (0), (b) weak (1+), (c) moderate (2+), and (d) strong (3+). Original magnification of 20×. * P < 0.05; ** P < 0.01; *** P < 0.001. NR/M, patients with no recurrence/metastasis within 2 years of hepatectomy; R/M ≤12 months , patients with recurrence/metastasis within 12 months of hepatectomy; R/M 12–24 months , patients with recurrence/metastasis within 12–24 months of hepatectomy.
Goat Anti Gal 4, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/galectin-4/Human%2FMouse%2FRat+Galectin-4+Antibody/pm38377735-68-34-38
Average 94 stars, based on 1 article reviews
goat anti gal 4 - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier
antibody human galectin  (R&D Systems)
93
R&D Systems antibody human galectin
<t>Galectin-4</t> is significantly downregulated in early recurrent/metastatic hepatocellular carcinoma (HCC). (a) Quantitative PCR analysis of galectin-4 expression in three HCC patient groups with different recurrence/metastasis time. (b) Western blot analysis of galectin-4 expression in three HCC patient groups with different recurrence/metastasis time. (c) Different galectin-4 expression levels in HCC tumor tissues and peri-tumor tissues. Galectin-4 expression was semiquantitatively categorized into four groups: (a) negative (0), (b) weak (1+), (c) moderate (2+), and (d) strong (3+). Original magnification of 20×. * P < 0.05; ** P < 0.01; *** P < 0.001. NR/M, patients with no recurrence/metastasis within 2 years of hepatectomy; R/M ≤12 months , patients with recurrence/metastasis within 12 months of hepatectomy; R/M 12–24 months , patients with recurrence/metastasis within 12–24 months of hepatectomy.
Antibody Human Galectin, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/galectin-4/Human+Galectin-4+Antibody/10__7554_slash_elife__72328-495-103-110
Average 93 stars, based on 1 article reviews
antibody human galectin - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier
biotinylated anti galectin antibodies  (R&D Systems)
94
R&D Systems biotinylated anti galectin antibodies
<t>Galectin-4</t> is significantly downregulated in early recurrent/metastatic hepatocellular carcinoma (HCC). (a) Quantitative PCR analysis of galectin-4 expression in three HCC patient groups with different recurrence/metastasis time. (b) Western blot analysis of galectin-4 expression in three HCC patient groups with different recurrence/metastasis time. (c) Different galectin-4 expression levels in HCC tumor tissues and peri-tumor tissues. Galectin-4 expression was semiquantitatively categorized into four groups: (a) negative (0), (b) weak (1+), (c) moderate (2+), and (d) strong (3+). Original magnification of 20×. * P < 0.05; ** P < 0.01; *** P < 0.001. NR/M, patients with no recurrence/metastasis within 2 years of hepatectomy; R/M ≤12 months , patients with recurrence/metastasis within 12 months of hepatectomy; R/M 12–24 months , patients with recurrence/metastasis within 12–24 months of hepatectomy.
Biotinylated Anti Galectin Antibodies, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/galectin-4/Human+Galectin-4+Biotinylated+Antibody/10__1158_slash_1078___0432__ccr___11___1462-41-13-18
Average 94 stars, based on 1 article reviews
biotinylated anti galectin antibodies - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier
gtm  (Proteintech)
93
Proteintech gtm
<t>Galectin-4</t> is significantly downregulated in early recurrent/metastatic hepatocellular carcinoma (HCC). (a) Quantitative PCR analysis of galectin-4 expression in three HCC patient groups with different recurrence/metastasis time. (b) Western blot analysis of galectin-4 expression in three HCC patient groups with different recurrence/metastasis time. (c) Different galectin-4 expression levels in HCC tumor tissues and peri-tumor tissues. Galectin-4 expression was semiquantitatively categorized into four groups: (a) negative (0), (b) weak (1+), (c) moderate (2+), and (d) strong (3+). Original magnification of 20×. * P < 0.05; ** P < 0.01; *** P < 0.001. NR/M, patients with no recurrence/metastasis within 2 years of hepatectomy; R/M ≤12 months , patients with recurrence/metastasis within 12 months of hepatectomy; R/M 12–24 months , patients with recurrence/metastasis within 12–24 months of hepatectomy.
Gtm, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/galectin-4/Galectin-4+Antibody/pm28441530-219-21-19
Average 93 stars, based on 1 article reviews
gtm - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier
recombinant human galectin 4  (R&D Systems)
90
R&D Systems recombinant human galectin 4
<t>Galectin-4</t> is significantly downregulated in early recurrent/metastatic hepatocellular carcinoma (HCC). (a) Quantitative PCR analysis of galectin-4 expression in three HCC patient groups with different recurrence/metastasis time. (b) Western blot analysis of galectin-4 expression in three HCC patient groups with different recurrence/metastasis time. (c) Different galectin-4 expression levels in HCC tumor tissues and peri-tumor tissues. Galectin-4 expression was semiquantitatively categorized into four groups: (a) negative (0), (b) weak (1+), (c) moderate (2+), and (d) strong (3+). Original magnification of 20×. * P < 0.05; ** P < 0.01; *** P < 0.001. NR/M, patients with no recurrence/metastasis within 2 years of hepatectomy; R/M ≤12 months , patients with recurrence/metastasis within 12 months of hepatectomy; R/M 12–24 months , patients with recurrence/metastasis within 12–24 months of hepatectomy.
Recombinant Human Galectin 4, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/galectin-4/Recombinant+Human+Galectin-4+Protein/bio_rxiv__2020__02__12__945204-173-30-45
Average 90 stars, based on 1 article reviews
recombinant human galectin 4 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
recombinant galectin binding  (R&D Systems)
94
R&D Systems recombinant galectin binding
<t>Galectin-4</t> is significantly downregulated in early recurrent/metastatic hepatocellular carcinoma (HCC). (a) Quantitative PCR analysis of galectin-4 expression in three HCC patient groups with different recurrence/metastasis time. (b) Western blot analysis of galectin-4 expression in three HCC patient groups with different recurrence/metastasis time. (c) Different galectin-4 expression levels in HCC tumor tissues and peri-tumor tissues. Galectin-4 expression was semiquantitatively categorized into four groups: (a) negative (0), (b) weak (1+), (c) moderate (2+), and (d) strong (3+). Original magnification of 20×. * P < 0.05; ** P < 0.01; *** P < 0.001. NR/M, patients with no recurrence/metastasis within 2 years of hepatectomy; R/M ≤12 months , patients with recurrence/metastasis within 12 months of hepatectomy; R/M 12–24 months , patients with recurrence/metastasis within 12–24 months of hepatectomy.
Recombinant Galectin Binding, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/galectin-4/Recombinant+Human+Galectin-4+Protein/pm41789075-74-1-13
Average 94 stars, based on 1 article reviews
recombinant galectin binding - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier

Image Search Results


Galectin-4 is significantly downregulated in early recurrent/metastatic hepatocellular carcinoma (HCC). (a) Quantitative PCR analysis of galectin-4 expression in three HCC patient groups with different recurrence/metastasis time. (b) Western blot analysis of galectin-4 expression in three HCC patient groups with different recurrence/metastasis time. (c) Different galectin-4 expression levels in HCC tumor tissues and peri-tumor tissues. Galectin-4 expression was semiquantitatively categorized into four groups: (a) negative (0), (b) weak (1+), (c) moderate (2+), and (d) strong (3+). Original magnification of 20×. * P < 0.05; ** P < 0.01; *** P < 0.001. NR/M, patients with no recurrence/metastasis within 2 years of hepatectomy; R/M ≤12 months , patients with recurrence/metastasis within 12 months of hepatectomy; R/M 12–24 months , patients with recurrence/metastasis within 12–24 months of hepatectomy.

Journal: Cancer Science

Article Title: Galectin-4 serves as a prognostic biomarker for the early recurrence / metastasis of hepatocellular carcinoma

doi: 10.1111/cas.12536

Figure Lengend Snippet: Galectin-4 is significantly downregulated in early recurrent/metastatic hepatocellular carcinoma (HCC). (a) Quantitative PCR analysis of galectin-4 expression in three HCC patient groups with different recurrence/metastasis time. (b) Western blot analysis of galectin-4 expression in three HCC patient groups with different recurrence/metastasis time. (c) Different galectin-4 expression levels in HCC tumor tissues and peri-tumor tissues. Galectin-4 expression was semiquantitatively categorized into four groups: (a) negative (0), (b) weak (1+), (c) moderate (2+), and (d) strong (3+). Original magnification of 20×. * P < 0.05; ** P < 0.01; *** P < 0.001. NR/M, patients with no recurrence/metastasis within 2 years of hepatectomy; R/M ≤12 months , patients with recurrence/metastasis within 12 months of hepatectomy; R/M 12–24 months , patients with recurrence/metastasis within 12–24 months of hepatectomy.

Article Snippet: A pool of three siRNA oligonucleotides for galectin-4 (sc-37102; Santa Cruz Biotechnology) and a negative control (sc-37007; Santa Cruz Biotechnology) were transfected into the HCCLM3 cells using Lipofectamine 2000 according to the manufacturer's instructions.

Techniques: Real-time Polymerase Chain Reaction, Expressing, Western Blot

In vitro migration and invasion analysis of HCCLM3 hepatocellular carcinoma cells with galectin-4 overexpression (a) or galectin-4 knockdown (d), confirmed by Western blotting. Representative images and quantification of results of migration and invasion of galectin-4 overexpressing cells (b, c) and galectin-4 knockdown cells (e, f). * P < 0.05; ** P < 0.01; *** P < 0.001. SiNon, Negative control with none target siRNA transfection.

Journal: Cancer Science

Article Title: Galectin-4 serves as a prognostic biomarker for the early recurrence / metastasis of hepatocellular carcinoma

doi: 10.1111/cas.12536

Figure Lengend Snippet: In vitro migration and invasion analysis of HCCLM3 hepatocellular carcinoma cells with galectin-4 overexpression (a) or galectin-4 knockdown (d), confirmed by Western blotting. Representative images and quantification of results of migration and invasion of galectin-4 overexpressing cells (b, c) and galectin-4 knockdown cells (e, f). * P < 0.05; ** P < 0.01; *** P < 0.001. SiNon, Negative control with none target siRNA transfection.

Article Snippet: A pool of three siRNA oligonucleotides for galectin-4 (sc-37102; Santa Cruz Biotechnology) and a negative control (sc-37007; Santa Cruz Biotechnology) were transfected into the HCCLM3 cells using Lipofectamine 2000 according to the manufacturer's instructions.

Techniques: In Vitro, Migration, Over Expression, Western Blot, Negative Control, Transfection

Kaplan–Meier analysis of the association between galectin-4 expression and recurrence/metastasis as well as the survival of patients with hepatocellular carcinoma. Those patients with negative galectin-4 expression ( n = 112) had significantly higher recurrence rate and shorter overall survival time than those with positive galectin-4 expression ( n = 89).

Journal: Cancer Science

Article Title: Galectin-4 serves as a prognostic biomarker for the early recurrence / metastasis of hepatocellular carcinoma

doi: 10.1111/cas.12536

Figure Lengend Snippet: Kaplan–Meier analysis of the association between galectin-4 expression and recurrence/metastasis as well as the survival of patients with hepatocellular carcinoma. Those patients with negative galectin-4 expression ( n = 112) had significantly higher recurrence rate and shorter overall survival time than those with positive galectin-4 expression ( n = 89).

Article Snippet: A pool of three siRNA oligonucleotides for galectin-4 (sc-37102; Santa Cruz Biotechnology) and a negative control (sc-37007; Santa Cruz Biotechnology) were transfected into the HCCLM3 cells using Lipofectamine 2000 according to the manufacturer's instructions.

Techniques: Expressing